60 Degrees Pharmaceuticals (NASDAQ:SXTP) Earns “Neutral” Rating from HC Wainwright

60 Degrees Pharmaceuticals (NASDAQ:SXTPGet Free Report)‘s stock had its “neutral” rating reiterated by analysts at HC Wainwright in a research note issued to investors on Wednesday, Benzinga reports.

60 Degrees Pharmaceuticals Stock Up 3.5 %

Shares of SXTP opened at $0.28 on Wednesday. 60 Degrees Pharmaceuticals has a 1 year low of $0.22 and a 1 year high of $8.65. The company has a 50 day simple moving average of $0.30 and a two-hundred day simple moving average of $0.61.

Institutional Investors Weigh In On 60 Degrees Pharmaceuticals

An institutional investor recently bought a new position in 60 Degrees Pharmaceuticals stock. Walleye Capital LLC bought a new stake in 60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTPFree Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 139,304 shares of the company’s stock, valued at approximately $103,000. Walleye Capital LLC owned approximately 2.40% of 60 Degrees Pharmaceuticals as of its most recent filing with the Securities & Exchange Commission. 7.96% of the stock is owned by institutional investors and hedge funds.

60 Degrees Pharmaceuticals Company Profile

(Get Free Report)

60 Degrees Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for respiratory viruses and dengue.

Recommended Stories

Receive News & Ratings for 60 Degrees Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 60 Degrees Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.